Additionally, our lab found that chemotherapy sensitive patients showed higher eIF3a expression in their lung cancers, which was partly ascribed to the role of eIF3a in the regulation of NER pathway proteins24. The gene discussed is EIF3A; the disease is lung carcinoma.